Lp HORIZON achieves 50% enrollment in trial to assess the safety and efficacy of pelacarsen in reducing recurrent cardiovascular events Pharmaceutical Investing
Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management Medical Device Investing
ALR Technologies Advances Partnership Discussions with Two Global Animal Health Pharmaceutical Companies Medical Device Investing
Bristol Myers Squibb Receives European Commission Approval for Opdivo as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy Biotech Investing
Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology Cannabis Investing News
